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Abstract 
 
Skiöldebrand E. 2004. Studies of articular cartilage macromolecules in the equine middle 
carpal joint, in joint pathology and training. 
Doctor’s dissertation 
ISSN 1401-6257, ISBN 91-576-6651-2 
 
Lameness caused by osteoarthritis (OA) is the most common reason for failure to race 
among horses. Degenerative changes to the articular cartilage are commonly seen often 
with subchondral bone sclerosis. Cartilage is a connective tissue with tensile strength and 
resilience, consisting of cells and abundant extracellular matrix. The cells are adapting the 
matrix to environmental conditions by synthesis and degradation of the matrix structural 
elements. A change in the concentration of macromolecules in synovial fluid and serum can 
indicate early biochemical changes in the joint. This provides a tool for research into and 
monitoring pathogenic mechanisms of OA. 
 
The content of COMP, aggrecan and collagen type II was measured in serum and 
synovial fluid (sf) from trotters and riding horses with either normal joints or joints with 
different stages of cartilage pathology. The trotters with a training background and cartilage 
degeneration had low concentrations of COMP and aggrecan in synovial fluid and serum as 
well as sf-collagen (paper I). The effect of long-term training on the concentration of sf-
COMP, -aggrecan and -collagen type II from young trotters was measured (paper II). The 
amount of training and age influenced sf-COMP, where lower concentrations were related 
to more training and higher age. The concentration of collagen type II degradation products 
increased with total days of training. In vitro dynamic compression of cartilage explants 
from trained horses showed a down-regulation of COMP synthesis compared to untrained 
horses (paper II). COMP in cartilage matrix was presented in an ultrastructural study (paper 
III), where COMP concentration, was much less abundant in loaded and unloaded matrix of 
articular cartilage from a strenuously trained horse compared to untrained horses. The 
untrained horses often displayed a higher immunolabeling in loaded areas compared to 
unloaded areas, indicating that dynamic load can promote COMP synthesis and /or 
retention, while excessive load have opposite effect.  
 
Galloping horses with osteochondral fractures had higher concentration of sf-COMP 
compared to normal or osteoarthtritic joints from trotters or galloping horses (paper IV). In 
conclusion the present work shows that strenuously training of racehorses alter the 
expression of macromolecules in the articular cartilage of the third carpal bone. 
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 Abbreviations 
 
ADAM/-TS-    A disintegrin and metalloprotease with thrombospondin repeat 
COMP      Cartilage  oligomeric  matrix  protein 
ELISA      Enzyme-linked  immunosorbant  assay 
GAG       Glycosaminoglycan 
Galloping horse Thoroughbred horse 
I L        I n t e r l e u k i n  
K S         K e r a t a n   s u l p h a t e  
MMP       Matrix  metalloprotease 
MT-MMP     Membrane-type  MMP 
OA        Osteoarthritis 
PRELP         Proline-arginine-rich end and leucine-rich repeat protein 
PsoA       Psoriatic  arthritis 
RA        Rheumatoid  arthritis 
Riding horse    Swedish Warmblood horse 
Sf-aggrecan    Concentration  of aggrecan in synovial fluid 
Sf-collagen      Concentration of collagen type II in synovial fluid 
Sf-COMP       Concentration of COMP in synovial fluid 
TIMP       Tissue  inhibitor  of  metalloproteases 
TNF      Tumour  necrosis  factor 
Trotter      Standardbred  trotter 
   11 
Background 
 
The horse racing industry suffers significant economic losses due to a high 
prevalence of lameness in racehorses (Rossdale et al., 1985).  
Osteoarthritis (OA) of the middle carpal joint is a common cause of lameness in 
racehorses and the medial aspect of the radial facet in the third carpal bone is the 
most common site of degenerative lesions (Fig. 1). These lesions include cartilage 
fraying and erosions, subchondral bone sclerosis and incomplete bone fractures 
(McIlwraith, 1982; Palmer, 1986; Pool & Meagher, 1990; Norrdin et al., 1998). 
Early stages of tissue changes in equine OA are impossible to detect clinically. 
An early diagnosis, with subsequent appropriate treatment and accurate 
convalescence program are of great value to prevent irreversible joint destruction. 
A lameness evaluation of the horse includes a clinical examination and palpation 
of the joints to identify and localise signs of heat, pain and swelling. Grading of 
the lameness before and after flexion tests, together with intra-articular anaesthesia 
can accurately localise the exact joint responsible for the lameness. The tissue 
destruction can be characterised by the aid of radiology, magnetic resonance 
imaging, ultrasonography, computed tomography, scintigraphy and diagnostic 
arthroscopy. However, clinical identification of early biochemical as well as 
microscopically catabolic processes of the cartilage and bone is not possible with 
techniques available today. Hence, molecular markers in synovial fluid and/or 
serum correlated to catabolic and anabolic processes in the joint tissues would be 
of great value.  
Most joint lesions are induced by acute trauma, repetitive load, or overload 
(Pool & Meagher, 1990). OA is defined as a joint disorder characterised by 
degeneration of the articular cartilage and sclerosis and /or microfractures of 
underlying bone with an inflammatory reaction in the synovial membrane and 
capsule (Sandell & Aigner, 2001). The pathophysiological mechanisms involved 
in OA are not fully understood. Findings implicate an alteration in the dynamic 
equilibrium between the biosynthetic phase (in which the chondrocytes synthesise 
and restore extracellular matrix) and the degradative phase (in which proteolytic 
enzymes are activated) (Sandell & Aigner, 2001). Release of different 
macromolecules and their fragments into synovial fluid and serum follow these 
anabolic and catabolic processes in the cartilage (Saxne & Heinegård, 1992). 
Hence, these macromolecules can be used as markers of cartilage homeostasis. 
This literature review covers Getty, 1975; Stryer, 1981; Poole, 1986; Mankin, 
1989; Mayne, 1989; Pool & Meagher, 1990; Buckwalter & Mow, 1992; Kuettner 
1992; Levick, 1992; Poole et al., 1995; McIlwraith, 1996; Pool, 1996; Grodzinsky 
et al., 1998; Heinegård et al., 1998; Lohmander & Felson, 1998; McCarthy & 
Frassia, 1998; Neame et al., 1999; Grodzinsky et al., 2000; Kawacak et al., 2001; 
Sandell & Aigner, 2001; Heinegård et al., 2002; Kielty & Grant, 2002; Martin & 
Buckwalter, 2002; McIlwraith, 2002; Morris et al., 2002; Murphy & Reynolds, 
2002; Stashak & Hill, Garrick & Requa, 2003, and includes several original 
references. References to review papers are identified by “rev” before the 
reference.   12
 
 
Figure 1. Macroscopic section of the proximal surfaces of the fourth, third and second 
carpal bones in the middle carpal joint of a four-year-old trotter. Moderate articular 
fraying and erosions of the third carpal bone are present at the radial facet (arrow). 
 
 
 
 
Literature review 
 
The carpal joint 
The carpal joint is a diarthrodial joint comprised of bony parts covered by hyaline 
cartilage. Its major functions are to absorb and distribute load and to enable low-
friction motion. The cartilage surfaces are separated by the joint cavity containing 
synovial fluid enclosed by a synovial membrane. The carpal joint is composed of 
three main joints with collateral and intercarpal ligaments including distal radius, 
carpal bones, and proximal metacarpal bones. The carpal bones consist of seven to 
eight bones arranged in a proximal and distal row (rev Getty, 1975) (Fig. 2). The 
proximal row contains radial-, intermediate-, ulnar- and accessory carpal bones 
and the distal row contains first (sometimes absent), second, third and fourth 
bones.  
The radial, intermediate and third carpal bones are axial weight bearing 
subjected to most of the load (Colahan et al., 1988). These three carpal bones and 
the distal radius are the most frequently injured parts of the joint (Bramlage et al., 
1988). The ulnar, and fourth and second carpal bones are subjected to minor load 
and the accessory carpal bone is non-weight bearing but interposed in flexor 
tendons (Colahan, et al.,1988; rev Getty, 1975). During the stride, the radiocarpal 
and middle carpal joints have a great range of movement compared to the more 
distal carpometacarpal joint. During the non-weightbearing phase, the different 
bones of the carpal joints do not fit perfectly, but when the hoof hits the ground, 
the bones slide into a locked position, absorbing large axial forces (Bramlage et 
al., 1988).    13 
Over-extension of the carpal joint (Fig. 3) during the weight bearing phase of 
the stride occurs due to the joint’s rotating action (Bramlage et al., 1983; Johnston 
& Roepstorff, 1995) and maximum overextension of the carpus is correlated with 
high trotting and galloping speeds (Johnston et al., 1995; rev Stashak & Hill, 
2002). During this overextension phase, the dorsal parts of the joints receive an 
excessive amount of vertical load causing high intrarticular pressure between the 
radial and third carpal bones (Johnston & Roepstorff, 1995). The dorsal part of the 
radial facet of the third carpal bone is also most prone to develop cartilage lesions; 
such as fraying, erosions, ulceration and subchondral bone sclerosis with 
incomplete fractures (Palmer, 1986; rev Pool & Meagher, 1990; Norrdin et al., 
1998). 
 
 
 
 
 
 
 
 
 
Figure 2. Macerated specimen of the equine carpal joint viewed dorsomedial. The radius, 
radial carpal, intermediate carpal and third carpal bone are indicated.  
(Photo: Cecilia Ley)   14
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Figure 3. Schematic drawing showing overextension of the carpal joint at gallop. 
 
Articular cartilage 
The articular cartilage is a connective tissue covering joint surfaces with 
specialised load-bearing properties, and the ability to withstand compressive, 
tensile, and shear forces due to the composition and structural integrity of its 
extracellular matrix (rev Grodzinsky et al., 1998). Adult articular cartilage is 
aneural, avascular, alymphatic and has a high matrix to cell ratio (rev Morris et al., 
2002; rev McIlwraith, 2002). The major constituents of this matrix are fibril-
forming collagen type II (giving the cartilage its tensile strength) and large 
aggregating proteoglycans (essential for its load-bearing properties). Collagen 
fibers and aggregating proteoglycans form a network together with non-
collagenous proteins responsible for the functional properties of the tissue (rev 
Heinegård et al., 2002). 
 
Morphology 
Adult articular cartilage is structurally arranged in four zones—superficial, 
intermediate, deep and calcified (Fig. 4) (Palmer & Bertone, 1994). The content of 
collagen is highest in the superficial zone with fibers orientated parallel to the 
surface. Collagen content decreases with increasing distance from the surface, 
while proteoglycan content shows a trend in the opposite direction (Poole et al., 
1982; rev McIlwraith, 2002). Extracellular water is more concentrated in the 
superficial layer, contributing to lubrication during load through fluid exudation 
into the synovial space. Chondrocytes in the superficial layer are oval and oriented 
parallel to the articular surface. The intermediate layer contains larger   15 
chondrocytes, single or paired in lacunes (chondrones), and randomly oriented. 
Proteoglycan content in the intermediate layer is higher than the superficial layer 
and has a network of obliquely oriented collagen fibrils (rev Morris et al., 2002). 
The deep layer is characterised by rounded chondrocytes often arranged in vertical 
columns separated by radially aligned collagen fibrils, with the highest 
proteoglycan content. The most basal layer is mineralised, separated from the non-
mineralised articular cartilage by a distinct thin layer of enhanced calcification—
known as the tidemark (rev Morris et al., 2002). Each layer has a different 
inherent biomechanical capacity due to different biochemical composition and 
collagen fiber arrangements.  
The fine structural organisation of the extracellular matrix can be divided into 
different compartments—the pericellular, territorial and interterritorial. The 
pericellular matrix, close to each cell (the lacunae), contains molecules interacting 
with the cell surface membrane providing feedback from the matrix. The territorial 
matrix (the capsular) surrounds the cell or groups of cells, with molecules 
regulating early stages of matrix assembly. The interterritorial matrix is the most 
abundant compartment occupying the intervening spaces at a distance from the 
cell. The main role of the extracellular matrix is to provide the unique 
biomechanical capacity of the articular cartilage (rev Heinegård et al., 2002). 
 
 
 
 
 
 
 
 
 
Figure 4. Micrographs of Tolouidine blue stained section of equine articular cartilage from 
the third carpal bone of a four-year-old trotter. 
Interterritorial matrix (large arrowhead) and territorial matrix (small arrowhead).   16
Molecular organisation 
The molecular organisation in articular cartilage is complex. This review focuses 
on macromolecules studied in this thesis (COMP, aggrecan and collagen type II) 
and other macromolecules of interest in adult articular cartilage with OA (Fig. 5). 
Articular cartilage is composed of a highly hydrated matrix in which the 
chondrocytes are embedded. The chondrocytes lack cell to cell contact and 
communication between cells occurs via the matrix (rev Kuettner, 1992). To adapt 
to changes within the matrix, the chondrocytes respond to signals (mechanical, 
electrical and physiochemical) in the pericellular microenvironment. This occurs 
through cell/matrix interactions responsible for cell proliferation, differentiation, 
and metabolism (Huber et al., 2000; Giannoni et al., 2003). 
Chondrocytes are responsible for synthesis, assembly and degradation of 
extracellular matrix constituents and cytokines, growth factors and degrading 
enzymes regulate the turnover of matrix constituents. Cartilage is a dynamic tissue 
that changes with many factors including age, mechanical load and inflammation 
with a continuous turnover of matrix constituents in order to meet changed 
functional needs. During homeostasis, the cartilage continuously undergoes 
remodelling and repair in which macromolecules of the extracellular matrix are 
continuously removed and replaced (Setton et al., 1999).  
In pathological processes such as OA, the balance between anabolic and 
catabolic processes is disturbed causing increased or decreased synthesis or 
degradation (rev Sandell & Aigner, 2001). 
 
CHONDROCYTE
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Figure 5. Schematic drawing of chondrocytes and their extracellular matrix, illustrating a 
limited number of macromolecules relevant for this Thesis and suggested future research. 
For complete matrix review see Heinegård et al., 2002.   17 
Aggrecan 
A major constituent of cartilage is aggrecan, a large macromolecule having a 
central core protein with many negatively charged glycosamnioglycan side chains 
covalently bound to it (rev Heinegård et al., 2002). The closely packed negatively 
charged groups attract and bind water and repel each other, leading to a large 
osmotic swelling pressure that contributes to the compressive stiffness of the 
articular cartilage (Heinegård & Oldberg, 1989; rev Heinegård et al., 1998). 
Several functional domains can be identified in the core protein.  
The first globular (G1) domain, in the amino-terminal part, allows a specific 
interaction with hyaluronan, stabilised by the link-protein enabling a large number 
of aggrecan molecules to bind to one molecule of hyaluronan (Hardingham & 
Muir, 1972). Aggrecan also consists of a second globular (G2) domain, with an 
unknown function, that is separated from the G1 domain by a short stretch of 
amino acids, the interglobular domain (IGD). A third globular (G3) domain, which 
appears to play a role in matrix assembly, is found at the carboxyl terminal part of 
the proteoglycan (Olin et al., 2001; rev Heinegård et al., 2002). Interposed 
between the G2 and G3 domains are the keratan sulphate (KS) and chondroitin 
sulphate (CS) attachment regions. The KS-region, with approximately 30 keratan 
sulphate chains, and the CS region with 100 some chondroitin sulphate chains 
bound to the core protein of a single proteoglycan monomer. KS and CS 
glycosaminoglycans consist of anionic polysaccharides with repeating 
disaccharide units each containing an amino sugar, (KS- glucosamine; CS- and 
galactosamine) and a hexose (KS) or hexuronic acid (CS). Each chain consists on 
average of 40 to 50 disaccharide units each with two negatively charged groups. 
The hexosamine carries a sulphate ester group as occasionally does the other 
sugar. Proteoglycan turnover primarily results in the release of large GAG 
substituted fragments cleaved between G1 and G2 domains (Ratcliffe et al., 1986), 
however further degradation results in the release of the G1 domain and link 
protein (Witter et al., 1987; Ratcliff et al., 1992). The enzymatic degradation is 
mediated by metalloproteases (stromelysin) and aggrecanases (ADAM-TS -4, -5, -
11) (Poole et al., 1995; Abbaszade, I. et al., 1999; Tortorella et al., 2000). 
 
Collagens 
The extracellular matrix in the articular cartilage is composed of a three-
dimensional crosslinked network of collagen type II (together with smaller 
amounts of other minor collagens such as collagen type IX, and XI) essential for 
the tensile strength and stiffness of the tissue (rev Mayne, 1989; Huber et al., 
2000, rev Kielty & Grant, 2002). Collagen type II represents 50% of the dry 
weight and 95% of the total collagen content in articular cartilage (rev Kuettner 
1992). The collagen type II molecule is fibril forming and composed of three 
identical polypeptide chains, [α1(II)]3, wound around each other forming a right-
handed triple helix.  
Chondrocytes synthesise and secrete collagen type II. Many modifications 
unique to collagen occur during biosynthesis. Collagen contains proline and 
lysine, and during synthesis hydroxylation of the residues results in the formation 
of hydroxyproline and hydroxylysine (rev Stryer, 1981) almost unique to 
collagens. The molecule, secreted as a procollagen, contains nonhelical propeptide   18
extensions at their amino- and carboxy terminal ends. The extensions are 
enzymatically removed, allowing the molecules to form fibrils. These are later 
stabilised by covalent, intermolecular crosslinks following modification of certain 
lysin residues by lysoloxidase, further increasing tensile strength (Eyre et al, 
1984).  
Other collagens in articular cartilage are also classified as fibril forming: 
collagen type III and XI, short-chain: collagen type VI and X, fibril-associated 
collagen with interrupted triple helices (FACIT): collagen type IX, XII, XIV. 
Collagen type XI, located within the interior of collagen type II fibrils probably 
organise type II molecules and determine the size of the final collagen fibril (rev 
Kuettner, 1992; Blaschke et al., 2000). Collagen type IX is covalently linked to 
the surface of collagen type II fibrils, which is believed to mediate fibril-fibril and 
fibril-proteoglycan interactions (Eyre, et al., 2004). Collagen type X, involved in 
calcification of matrix, is present in the growth plate around hypertrophic 
chondrocytes and in the calcified zone of articular cartilage (Grant et al., 1985). 
Collagen type VI, located in the pericellular compartment is proposed to have a 
bridging function between chondrocyte and matrix. (Horikawa et al., 2004). 
Collagen type III fibrils are rarely found in normal articular cartilage (Young et 
al., 2000). 
Collagenases (MMP-1, -2 –8, -13 and –14) cleave the collagen molecule, with 
ensuing unwinding the helical structure with subsequent susceptibility to 
degradation by other proteases (Murphy et al., 1987; rev Murphy &Reynolds, 
2002). 
 
Non-collagenous proteins 
Articular cartilage also consists of non-collagenous matrix proteins (rev Heinegård 
et al., 2002) which are important for the interaction and assembly of the various 
macromolecules. These molecules have different functions and interact 
specifically with other matrix molecules, either contributing to the structural 
network or interacting directly with the chondrocytes by modulating the phenotype 
(rev Neame et al., 1999). 
 
Leucine rich repeat proteins 
A major non-collagenous protein family of the extracellular matrix is the small 
leucine-rich repeat proteins (sLRP), some of which contain glycosaminoglycan. 
These proteins have a central leucine rich repeat (LRR) domain and represent an 
important superfamily known to participate in protein-protein interactions 
(Hocking  et al., 1998). They are sub-grouped according to their amino acid 
sequences and gene organisation. Several sLRPs are found in cartilage including 
decorin, biglycan, asporin, fibromodulin, lumican, PRELP (proline-arginine-rich 
end leucine-rich repeat protein), ephiphycan and chondroadherin. 
Decorin and biglycan, interact with collagens via the LRR domain (Oldberg et 
al., 1989), and asporin (which is structurally related to biglycan and decorin but 
without glycosaminoglycan chains) is upregulated in articular cartilage in early 
OA (Lorenzo et al., 2001). PRELP, a heparin binding protein, binds to a basement 
membrane proteoglycan—perlecan via its heparin-binding domain. Additional, 
PRELP binds to collagen type I and II via the LRR domain. The putative role for   19 
this protein is to anchor the basement membranes to the underlying tissue 
(Bengtsson et al., 2002). 
Chondroadherin interacts with chondrocytes and fibroblasts via a surface 
receptor (integrin α2β1) (Camper et al., 1997). Chondroadherin also binds to two 
sites on collagen type II (Månsson et al., 2001a), and collagen type VI (Wiberg et 
al., 2002) with probable functional importance in regulating collagen fibril 
assembly and anchor the cell to matrix. Chondroadherin is localised in the 
territorial matrix of late proliferative cells in the growth plate and in articular 
cartilage of the maturing femoral head of the rat. The protein may have an 
important role in the regulation of chondrocyte proliferation and growth (Shen et 
al., 1998). Biglycan, decorin and chondroadherin have the ability to interact with 
collagen type VI and biglycan or decorin with GAG–chains can organise the 
molecule into extensive hexagonal-like networks (Wiberg et al., 2002). 
 
Fibronectin 
Fibronectin is found in most tissues and body fluids, binding to cell surfaces via 
several different integrin receptors and integrin subunits α5β1 to chondrocytes 
(Lucchinetti  et al., 2004). Mechanical load up-regulates the synthesis of 
fibronectin in bovine explants and in osteoarthritic joints (Xie et al., 1992; Wong 
et al., 1999). Additional fragments of fibronectin can initiate degradation and 
release of COMP and chondroadherin, inducing production of nitric oxide from 
equine cartilage explants in vitro (Johnson et al., 2004).  
Increased concentration of fibronection has also been found in cartilage 
explants (Burton-Wurster et al., 1999) and synovial fluid (Lust et al., 1997) from 
OA joints in dogs. 
 
Cartilage intermediate layer protein (CILP) 
CILP, present in the middle/deep layer of articular cartilage increases in 
concentration with age. The function of the protein is not known, though its 
restricted distribution in the articular cartilage suggests a specific function 
(Lorenzo et al., 1998). 
 
Cartilage Oligomeric Matrix Protein (COMP) 
COMP is a glycoprotein belonging to the thromospondin family also named 
thrombospondin 5. COMP is made up of five identical subunits (pentamer) linked 
together at their N-terminal part via a coiled coil domain stabilised by disulphide 
bonds. Each subunit continues with a flexible arm that contains four epidermal 
growth factor (EGF) domains and seven calcium-binding domains (Zaia et al., 
1997). The chains end with a C-terminal globular domain creating a bouquet that 
is tulip-like appearance (Mörgelin et al., 1992). The intact pentamer is 435 kDA in 
size, and is dissociated by reduction of disulphide bonds resulting in 5 subunits on 
86,949 kDa (Zaia et al., 1997).  
The COMP molecule consists of 737 amino acids. The distribution in different 
parts of cartilage as well as between cartilages differs. The protein is present in the 
territorial matrix of the growth plate (Ekman et al., 1997) and immature cartilage 
(Shen et al., 1995) and the interterritorial matrix of the adult articular cartilage   20
(Shen  et al., 1995). Its function is not fully understood but it interacts with 
collagen type I, II (Rosenberg et al., 1998) and IX molecules (Thur et al., 2001; 
Holden et al., 2001) through the C-terminal domain and catalyses the assembly of 
collagen type I and II into fibrils in vitro (Rosenberg, PhD Thesis 2001). COMP 
also interacts with fibronectin found in the extracellular matrix of cartilage (Di 
Cesare et al., 2002) and is found in tendon (Di Cesare et al., 1994; Smith et al., 
1997), and in trace amounts in synovial membrane (DiCeasare et al., 1997). 
However, the concentration of COMP in intra-articular ligaments and synovial 
membrane of the equine middle carpal joint is a thousand and hundred-fold lower, 
respectively, than in synovial fluid (Skiöldebrand et al., 2001).  
COMP plays an important role in cartilage development and mutations in the 
gene give rise to multiple epiphyseal dysplasia (Hecht et al., 1998) and 
pseudoachondroplasia (Briggs et al., 1995) characterised by limb dwarfism and 
cartilage abnormalities. Suprisingly, COMP-deficient mice have normal skeletal 
development suggesting that mutations in the gene result in defects of the protein 
or abnormalities in matrix assembly, rather than reduced amounts of COMP 
(Svensson et al., 2002).  
The enzymes responsible for COMP degradation in vivo have yet to be 
identified. Bovine explants stimulated with Il-1 release aggrecan prior to COMP, 
which in turn was released prior to collagen (Dickinson et al., 2003). COMP was 
cleaved by ADAMTS-4 (a disintegrin and metalloprotease with thrombospondin 
repeat) creating fragments with an apparent molecular mass of approximately 110 
kDa similar to fragments of COMP released in OA synovial fluid. 
 
Age-related changes in articular cartilage 
Age changes in cartilage matrix are mostly related to a decline in the ability of the 
cells to synthesise and assemble matrix macromolecules (rev Martin & Buckwalter 
2002). Macromolecular homeostasis in ageing healthy joints must be considered 
when interpreting pathological processes occurring in OA. Age-related articular 
cartilage degeneration such as fibrillation is the most obvious structural change, 
not always associated with joint pain or dysfunction in humans (Byers et al., 1970; 
Koepp et al., 1999). There is a strong relationship between increased levels of 
pentosidine crosslinks and degeneration in articular cartilage in man, resulting in a 
stiffer collagen network more susceptible to mechanical load (Verzijl et al., 2000). 
Additional, increased pentosidine crosslink levels are present in articular cartilage 
from older horses (Brama et al., 1999). Articular cartilage degeneration was found 
to increase with age, suggesting that OA also may be a natural occurring age-
related process in the horse (Brommer et al., 2003a). 
Age-related articular cartilage fibrillation does not necessarily lead to 
progressive articular cartilage degeneration present in OA (rev Martin & 
Buckwalter, 2002). Low metabolic activity in chondrocytes with a decreased 
responsiveness to growth factors have been found in articular cartilage from old 
horses compared to young horses (Iqbal et al., 2000; Morries & Treadwell, 1994). 
Also, an age-related decrease in the ratio of cell (DNA) to matrix (dry-weight) has 
been described in equine articular cartilage from weight bearing areas of the 
metacarpophalangeal joint (Platt et al., 1998; Brama et al., 2002). This is in 
agreement with studies of human articular cartilage showing decreased cellularity   21 
correlated to higher age (Vignon et al., 1976; rev Martin & Buchwalter, 2002). It 
is suggested ”that the functional adaptation of articular cartilage, as reflected in the 
function of biochemical heterogeneity in the horse, occurs for the most part during 
the first 5 month post-partum” (Brama et al., 2002). 
In synovial fluid of neonates, high concentrations of hydroxyproline , GAG and 
MMP were found (van den Boom et al., 2004), and during maturation the 
concentrations decreased. However, in horses more than 4 years of age the 
collagen content and hydroxyproline and GAG concentrations did not change with 
age in adult horses (Brama, et al., 1999; van den Boom, et al., 2004). This is in 
agreement with GAG in synovial fluid from different equine joints (8-30 years) 
(Fuller  et al., 1996). The total proteoglycan content (mainly composed of 
aggrecan) remains constant with age in equine articular cartilage, however a 
heterogeneity in size of the proteoglycans, with an increased level of free 
hyaluronan binding region suggesting a retained functional capacity to aggregate 
is present (Platt et al., 1998). Also, there is an age-related change in sulphation of 
newly synthesised and endogenous proteoglycans, in human (Hardingham & 
Bayliss, 1990; Bayliss et al., 1995) and equine (Platt et al., 1998) articular 
cartilage. The decrease in sulphation at the 6 loci compared to the 4 loci of CS in 
equine and the increase in the 6-sulphation and decrease in 4-sulphation of CS in 
human (Bayliss et al., 1995) suggest a species related difference in the 
sulphotransferas enzyme. The content of hyaluronan in equine and human articular 
cartilage increases with age, presenting more binding sites for protoglycan 
monomers (Hardingham & Bayliss, 1990; Platt et al., 1998). The structures of 
decorin and link protein in equine articular cartilage of metacarpophalangeal joints 
are similar in size and change with age (Platt et al., 1998). No significant 
correlation is found between KS, total GAGs, and age in synovial fluid from 
different equine joints (Fuller et al., 1996).  
The biochemical characteristics of the collagen network such as water and 
collagen content, lysylhydroxylation, and crosslinking of hydroxylysylpyridinoline 
in equine articular cartilage of the proximal first phalanx does not change with age 
(4 to 30 years) (Brama et al., 1999). No significant correlation between age and 
concentration of COMP in serum was found but the concentration of KS in serum 
from young horses was higher compared to the older horses (Misumi et al., 2002). 
Collagenase (MMP-1) and stromelysin (MMP-3) activity in synovial fluid 
declined with maturation of the joint after high activity in foetal joints, suggesting 
a rapid tissue turnover necessary for maturation of the tissue (Brama et al., 2000; 
Brama et al., 2004). 
 
Load-related changes in articular cartilage 
It is well known that immobilisation of joints or lack of exercise negatively affects 
the metabolism of articular cartilage and that exercise is necessary to maintain 
normal cartilage homeostasis (Richardson & Clark, 1993; van den Hoogen et al., 
1999). Also lack of exercise during the first 5 months of life delay the functional 
adaptation of the collagen network in equine articular cartilage (Brama et al., 
2002). 
In vivo, axial, shear, and tensile strains are produced in cartilage when loaded 
(rev Grodzinsky et al., 2000). In general, static compression of cartilage, in vitro,   22
decreases synthesis of proteoglycans, most likely due to reduction in cell and 
nucleus structures (Buschmann et al., 1996). However, low-amplitude dynamic 
compression in vitro with different frequencies stimulates chondrocyte metabolism 
(Sah et al., 1989). Injurious dynamic compression of articular cartilage, in vitro, 
results in cell necrosis and apoptosis (Chen et al., 2001; Kurz et al., 2001).  
The exact level of exercise for an adequate dynamic load, beneficial for 
physiologic turnover of matrix constituents is not known. Mechanical load 
classified as overload or repetitive load is not a static process and the 
transformation from physiologic load to overload with a subsequent dominance of 
catabolic processes is not well characterised. The cellular responses in in vitro 
compression studies are difficult to compare since different loading and labeling 
times are used, and normal turnover of many proteins is not known. 
Physical and structural alterations occur in articular cartilage during dynamic 
compression, including cell and nucleus deformation, extracellular matrix changes 
in fluid flow, streaming potentials and currents, altered water content, and fixed 
charge density. All these parameters have been found to modulate matrix 
metabolism after compression in vitro (rev Grodzinsky et al., 1998). 
The modulation of metabolic activity in tissue caused by mechanical load is 
orchestrated by the chondrocytes (Wu & Chen, 2000; Buschmann et al., 1996), 
which can respond through stretch-activated ion channels and integrin signalling. 
Mechanical load has been found to increase the number of integrin subunit α5 
(Lucchinetti et al., 2004) and subunit β-1 in articular cartilage (Giannoni et al., 
2003). These subunits form the receptor for fibronectin, a matrix protein involved 
in mechanotransduction (Millward-Sadler et al., 2000; Enomoto et al., 1993) and 
regulation of cytokine production (Arner & Tortorella, 1995).  
The equine third carpal bone in the middle carpal joint is characterised by 
different load-bearing regions of the proximal articular surface (Palmer et al., 
1994). Contact area and pressure distribution changes during load and the dorsal 
part of the radial facet is subjected to a high load compared to the palmar aspect of 
the intermediate facet, characterised as an unloaded non-contact area (Palmer et 
al., 1994). The articular cartilage from moderately and strenuously trained horses 
has a similar total DNA content in loaded and unloaded areas (Little et al., 1997) 
indicating no cell loss. A significant reduction in aggrecan and increase in decorin 
synthesis is present in the dorsal radial facet of articular cartilage from long-term 
strenuously trained racehorses. The abnormalities in proteoglycan biosynthesis are 
retained four months after termination of the training (Little et al., 1997). No 
change in biglycan synthesis or ability of aggrecan to aggregate was found.  
Short-term, high-speed training in trotters will increase KS concentration in 
synovial fluid (Yovich et al., 1993), as is also found in serum of human athletes 
after running for 1-1.5 hours (Roos et al., 1995). After long-term strenuous 
training of 2-year-old galloping horses, a decrease in hydroxylysylpyridinoline 
(HP) crosslinking in the proximal first phalanx (Brama et al., 2000a) and a 
difference of collagen content and crosslinking between sites in the equine 
articular cartilage of this bone is reported (Brama et al., 1999). The areas 
subjected to constant load show a lower collagen content, HP and pentosidine 
crosslinks than the dorsal areas subjected to intermittent peaks of load. 
The collagen content was also significantly lower in the dorsal area of the third 
carpal bone of the middle carpal joint in galloping horses exposed to high-  23 
intensity training compared to those in low-intensity training (Murray et al., 
2001a). These findings suggest that the collagen network is influenced and 
damaged in strenuous training. Also, lower serum concentrations of CPII were 
found in five-month old foals exposed to training compared to rested foals and 
foals in pasture—suggesting a negative effect on the collagen turnover in relation 
to forced exercise early in life (Billinghurst et al., 2003). 
COMP expression in articular cartilage is also correlated to load. COMP and 
fibronectin is up-regulated in bovine adult cartilage explants subjected to cyclic 
unconfined compression in vitro (Wong et al., 1999). The up-regulation may be an 
attempt by the cartilage to stabilise the extracellular matrix in response to the 
compression. Cell/receptor/matrix interactions are important in the transduction of 
mechanical signals. The up-regulation of COMP could be blocked with antibodies 
against the integrin subunits β-1, suggesting activation of a matrix/receptor 
complex (Giannoni et al., 2003). 
Distribution of COMP, assessed by light microscopic immunohistochemistry, is 
more prominent in the interterritorial compartments of articular cartilage from 
horses undergoing a 19-week high-intensity training program (Murray et al., 
2001b) compared to non-exercised horses. In the latter, a generalised distribution 
in territorial and interterritorial compartments is found, suggesting exercise related 
enhancement of the structural maturity of the articular cartilage. This 
reorganisation of COMP is also present in articular cartilage from older 
individuals (King and Heinegård, unpublished data).  
The content of COMP also differs in loaded and unloaded equine articular 
cartilage with lower concentration of COMP in the dorsal areas of radial facet 
compared to the palmar areas of the intermediate facet of the third carpal bone in 
exercised horses (Murray et al., 2001b). A correlation between COMP and load is 
also present in other connective tissues. The concentration of COMP in equine 
tendons varies with age and tendon type with low levels in the neonatal tendon 
and an increase in concentration up to the age of three years (Smith et al., 1997). 
The superficial digital flexor tendon, which experiences a high load, has a high 
concentration of COMP compare to the deep digital flexor tendon and extensor 
tendon.  
Another non-collagenous protein in cartilage, fibronectin, is also affected by 
load. Increased fibronectin content, assessed by light microscopic immuno-
chemistry, is present in articular cartilage from loaded area of the third carpal bone 
in two-year-old galloping horses that were strenuously trained for 19 weeks, 
compared to non-trained horses (Murray et al., 2000). 
Biomechanical properties such as the aggregate modulus and permeability 
constant of the articular cartilage from the third carpal bone were assessed by 
creep indentation testing (Palmer et al., 1995). Exercise significantly increased the 
permeability constant, suggesting an increased fluid movement through the 
articular cartilage, resulting in thinner cartilage. Similar results were found in 
young galloping horses strenuously trained for 19 weeks. The articular cartilage of 
the middle carpal joint, assessed by creep indentation, showed less permeability, 
and was thinner in the loaded area of the third carpal bone as compared to 
untrained horses (Murray et al., 1999). 
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Joint diseases 
Joint diseases in horses have been categorised into three main groups, according to 
etiologic factors: traumatic, developmental, and infectious (rev McIlwraith, 1996).  
In man, more than 100 specific diagnostic entities of joint diseases exist, with 
the most common being, degenerative, inflammatory and metabolic (rev McCarthy 
& Frassia, 1998). Degenerative joint disease is mainly exemplified by OA; the 
inflammatory by rheumatoid arthritis (RA), reactive arthritis and psoriatic arthritis 
(PsoA); and the metabolic by gout and calcium pyrophosphate deposition disease. 
Other major disease categories in humans include traumatic and infectious disease 
that can lead to OA when no successful healing is achieved. 
OA comprises a heterogeneous group of disorders in the joints with pain and 
loss of joint function. OA in humans and equine has been defined in various 
ways—degenerative joint disease, osteoarthrosis, primary and secondary OA—
which has led to confusion when comparing the aetiopathogensis. Osteoarthritis 
and osteoarthrosis are often used interchangeably, but it is useful to remember the 
difference between them. The latter being joint failure from primarily degenerative 
changes whereas osteoarthritis are primarily an inflammatory process with 
secondary degenerative changes (Radin, 1995). Differentiating between the two is 
often impossible since the difference is found only in the acute event. Both 
osteoarthritis and osteoarthrosis result in a mixture of inflammatory and 
degenerative processes within the joint. There appears to always be a component 
of inflammation in OA. Hence, the term osteoarthritis (OA) will be used 
throughout this thesis.  
The aetiopathogenesis of OA is multifactorial and differs between man (Dieppe, 
1995) and horse (rev McIlwraith, 1996). OA in man often has an age-related 
factor (rev Mankin, 1989) not as predominant in equine OA (Brommer et al., 
2003a). Excessive, rapid and repetitive load has been suggested to induce joint 
damage and is an important factor in clinical OA of racehorses (Bramlage et al., 
1988; rev Pool & Meagher, 1990) and athletes (rev, Garrick & Requa, 2003).  
OA in the horse is characterised by articular cartilage degeneration, subchondral 
bone sclerosis, bone necrosis, marginal osteophytes, and inflammation of the 
synovial membrane (synovitis), capsule (capsulitis) and ligaments (rev 
McIlwraith, 1996). Synovitis is almost always present and the reaction is reported 
to range from mild synovitis to more severe degenerative joint disease 
(McIlwraith, 1982). Joints differ in form and function, and joints of the limbs 
develop unique patterns of changes—where the carpal, fetlock, distal intertarsal 
and tarsometatarsal joints are most commonly affected (rev Pool, 1996). 
Subchondral bone sclerosis is often found in OA of the carpal joints of 
racehorses (Norrdin et al., 1998), and it has been suggested that bone sclerosis 
precedes cartilage fibrillation (Hayami et al., 2004). A sclerotic bone is less elastic 
and may have a reduced ability to dissipate and absorb load (Radin & Rose, 1986). 
In an assessment of cartilage and bone lesions (by magnetic resonance imaging—
MRI), in carpal joints of racehorses, the different cartilage lesions were related to 
the degree of sclerosis in the underlying bone (Anastasiou et al., 2003). However, 
the sequence of events in the interactions between articular cartilage and 
subchondral bone is not fully understood (rev Kawcak et al., 2001).  
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Articular cartilage changes in osteoarthritis 
The normal articular cartilage is a metabolically active tissue with a balance 
between anabolic and catabolic processes (rev Heinegård et al., 2002). In OA, an 
imbalance occurs between synthesis and the degradation rate of cartilage 
extracellular matrix components, inflammatory mediators released from the 
synovium as well as changes in the subchondral bone (Fig. 6). Joint surface 
osteoarthritis is grossly characterised by a roughening and fibrillation of the 
superficial cartilage and in late stages, erosions with denuded bone and the 
formation of osteophytes. Histologically, superficial fibrillation together with 
chondrocyte necrosis and proliferation (chondrocyte clustering) to vertical clefts 
and full thickness loss of articular cartilage are seen (rev McIlwraith, 1996; rev 
Sandell & Aigner, 2001). 
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Figure 6. Suggested cellular responses in equine osteoarthritis. 
 
Biochemical reactions in osteoarthritic cartilage are complex with degenerative 
and repair processes present simultaneously. Early cartilage degeneration induced 
by proinflammatory enzymes is characterised by a net loss of proteoglycans and 
increased tissue volume (Mankin et al., 1971; Maroudas, 1976). KS concentration 
is significantly increased in serum prior to the onset of macroscopic cartilage 
damage in dogs with ligament transection of the knee (Manicourt et al., 1991). 
When proteoglycan loss has reached a certain level, degradation of the collagen   26
network follows with disruption of the network leading to tissue swelling and loss 
of tensile properties (Maroudas, 1976). The synthesis of collagen has a slow 
turnover rate, so damage to collagen type II fibrillar network is a critical event in 
disease progression (Maroudas, 1976; Verzijl et al., 2000). Phenotype alteration of 
the chondrocytes in ostearthritic cartilage with ensuing synthesis of proteoglycans 
of heterogeneous size and collagen type I (fibrocartilage), results in matrix being 
less resistance to mechanical load (rev Poole, 1986; Pfander et al., 1999).  
Although the chondrocytes increases its anabolic activity as an attempt to repair, 
the tissue is characterised by increased enzymatic degradation. Proinflammatory 
cytokines such as IL-1, -6, -17, -18 and tumour necrosis factor alpha (TNFα) 
stimulates chondrocytes and synovial cells to synthesise proteases and nitric oxide 
with subsequent matrix degradation (rev Sandell & Aigner, 2001; Min et al., 
2001). Proteases, especially metalloproteases (MMP), are important enzymes in 
cartilage degradation. MMPs are classified into collagenases, gelatinases, 
stromelysins, matrilysins, ADAMs and MT-MMP (membrane-type MMPs). 
Collagenases (MMP -1, -2, -8, -13 and 14), cleave and degrade fibrillar collagen at 
a single bond, three-quarters of the way along the collagen molecule from the N-
terminus, thereby destabilising the conformation (Gadher et al., 1988). 
Stromelysins (MMP -3, -10 and -11) degrade proteoglycans, and collagens such as 
collagen types II, IX, XI. Gelatinases (MMP -2 and -9) degrade gelatin and 
unwound collagen. ADAMS-TS -4 and -5 (aggrecanase) cleave the aggrecan 
molecules at specific sites (Tortorella et al., 2000). The inactive form of the 
MMPs can be activated by stromelysin or MT- MMPs (Woessner, 1991; Murphy 
et al., 1990). 
Production of MMPs by equine chondrocytes and subsequent cartilage 
degradation has been induced by TNFα and Il-1 ß (Alwan et al., 1991b; 
Billinghurst et al., 1995; Clegg & Carter, 1999; Trumble et al., 2001). However, 
the activity of TNFα in synovial fluid does not correlate to the degree of joint 
destruction in horses as does the activity of MMP -9, where high levels are found 
in joints with severe cartilage lesions (Joughlin et al., 2000). High concentrations 
of MMP -2 and -9 are present in synovial fluid from equine aseptic arthritic joints 
(Clegg et al., 1997; Trumble et al., 2001). Also, high MMP activity as well as high 
concentrations of MMP -3 and MMP -1 are found in synovial fluid from OA joints 
(Brama et al., 1998; 2000; 2004). Regulation of MMPs is achieved by controlling 
production and activation of the pro-enzymes together with the presence of 
inhibitors, such as tissue inhibitors of metalloproteases (TIMP) (Clegg et al., 
1998). 
 
Molecular markers in joint disease  
The early stages of cartilage and bone changes in OA are impossible to define and 
monitor, hence there is a search for biochemical and immunological markers that 
indicate the disease process. In order to prevent the onset of tissue destruction and 
progression, it is crucial to find molecular markers that can be used to monitor 
inflammatory and catabolic as well as anabolic processes in cartilage and bone 
(Heinegård & Saxne, 1991; Lohmander et al., 1995).  
A set of synovial fluid and serum markers, indicating events in different 
compartments of the joint tissues would be valuable in monitoring tissue   27 
destruction and repair over time. These markers could also be used to diagnose, 
prognosticate, and evaluate therapeutic intervention. The effects of load, 
inflammation and age on the degradation, remodelling and synthesis of matrix 
molecules in connective tissues could be evaluated using such markers. 
Molecular markers are classified as inflammation and skeletal markers 
(Otterness  et al., 2000). Inflammation markers, comprise MMPs (Clegg et al., 
1997; Brama et al., 1998; 2000b; 2004), cytokines (Morris EA et al., 1990, 
Bertone et al., 2001, Billinghurst et al., 1995) acute phase proteins (Hultén et al., 
2002; Otterness, 1994) and hyaluronan (Tulamo et al., 1996). However, this 
review concentrates on skeletal markers and in particular, markers of cartilage 
metabolism. 
Skeletal markers comprise constituents of cartilage and bone extracellular 
matrix. Specified concentrations of these tissue derived markers in body fluid 
compartments (synovial fluid, serum and urine) may serve as a window of 
ongoing pathological processes in the joint (Saxne et al., 1993; Lohmander et al., 
1998; Petersson et al., 1997, 1998). Skeletal markers are related to anabolic and 
catabolic processes of cartilage and bone matrix (Otterness et al., 2000; rev 
Lohmander & Felson, 1998). The correlation between metabolic processes in the 
joint and the concentration of markers in synovial fluid is influenced by such 
parameters as: degradation/synthesis rate of the matrix constituents; amount of 
tissue, cell viability and intensity of inflammation—as the rate of elimination from 
the joint fluid compartment increases with inflammation (rev Levick, 1992; Myers 
et al., 1996). Concentrations of molecular markers in serum and urine are further 
dependent on the rate of elimination by lymph nodes, liver and kidney (Fig. 7). 
 
 
 
 
   28
Protein molecule degraded
Molecular fragments Intact molecule
Protein molecule not degraded
CARTILAGE
SYNOVIAL FLUID
SYNOVIAL MEMBRANE
BLOOD VESSEL
LYMPH VESSEL & NODE
Kidney Liver
© Li Gessbo
Chondrocyte
 
 
Figure 7. Schematic drawing illustrating elimination of cartilage matrix constituents. 
 
The concentration and fragmentation of a certain molecular marker in synovial 
fluid can reflect the tissue metabolism of the specific joint (Heinegård et al., 1985; 
Heinegård & Saxne, 1991; Saxne & Heinegård, 1992). Serum, however, contains 
intact or degraded macromolecules released from many joints, reflecting systemic 
changes (Simkin et al., 1995). Also, human joint cartilage represents less than 
10% of the total body hyaline cartilage, hence, serum concentrations of a cartilage 
derived macromolecule will reflect pathological changes in other organs than 
joints (rev Lohmander & Felson, 1998).  
Cartilage matrix molecules originate from newly synthesised molecules never 
incorporated in the matrix or resident molecules released as degraded or intact 
molecules. In addition, the released molecules originate from different 
compartments in the matrix (pericellular, territorial and interterritorial) and/or 
from different morphological layers (superficial, intermediate and deep) of the 
articular cartilage (rev Lohmander & Felson, 1998). 
The results of the many studies of skeletal markers in OA can be difficult to 
compare since different methods are often used. It is important to consider the type 
of joint, the pathological changes, the age, and the athletic activity of the horse 
when comparing results. 
KS concentration in serum, (as measured by an inhibition ELISA using 
monoclonal antibodies against a sulphated epitope on KS (5D4)), was significantly 
higher in horses with OA joints compared to normal, however no difference in 
synovial fluid from normal and OA joints was noted. (Okumura et al., 1998). 
Significantly increased levels of KS in synovial fluid and serum, assessed by an 
identical immunoassay and glycosaminoglycans measured by a specific dye   29 
binding assay (DMB) were found in fetlock and carpal joints of horses with OA as 
compared to normal joints (Alwan et al., 1990). However, using an identical 
immunoassay, KS in synovial fluid from fetlock and carpal joints of galloping 
horses, subjected to arthroscopy after a short period of lameness, decreased in 
correlation to the severity of pathological changes (Fuller et al., 2001). But, this 
comparison was made between the clinically active joint (lame) and the 
contralateral joint, not clearly defined as normal. Also, a low KS concentration in 
synovial fluid from osteoarthritic carpal joints has been reported (Todhunter et al., 
1997). The differences presented in these studies can be due to different athletic 
profiles of the horses, different definition of OA and/or different activity of the 
inflammation in the osteoarthritic joints. 
High levels of GAGs (DMB-assay) were found in synovial fluids, serum, and 
urine from horses with OA and in each case, the level was higher in the synovial 
fluid than in the serum or urine from the same horse (Alwan et al., 1991a). High 
levels were also found in horses with osteochondritis dissecans and traumatic 
arthritis, but not in normal or infected joints. A change in glycosaminoglycan 
structure depicted by the 846 epitope on chondroitin sulphate is an indicator of 
altered proteoglycan metabolism. High levels of this epitope were found in 
synovial fluid and serum from horses with osteochondral fractures of the carpal 
joints as compared to healthy joints. As well, an elevated concentration of CPII 
(pro-peptide of collagen type II)—an indicator of collagen type II production in 
serum from horses with fractured joints was found (Frisbie et al., 1999). Further, a 
significant increase in CPII and a decrease of 846 and KS epitopes were present in 
young horses with osteochondrosis (Laverty et al., 2000). Collagen type II 
fragments [COL2-3/4C], biomarkers of collagen degradation (collagenase-
generated neoepitopes of type-II collagen fragments) in serum, are indicators of 
the severity of osteochondrosis in foals, aged 5 months (Billinghurst et al., 2004). 
However, osteochondrosis in foals, aged 11 months, showed lower concentrations 
of [COL2-3/4C] and higher of CPII in serum, indicating reparation. In another 
study (van den Boom et al. 2004), no increase in concentrations of hydroxyproline 
(high-performance liquid chromatography) and GAG (DMB-assay) in synovial 
fluid from horses with OA compared to unaffected joints was found. However, 
hydroxyproline was positively correlated with cartilage degeneration index and 
MMP activity. 
COMP has been an extensively studied candidate in the search for molecular 
markers of OA in man. COMP concentrations in synovial fluid and serum increase 
in RA, reactive arthritis, and in early stages of osteoarthtritis (Forslind et al., 1992; 
Saxne et al., 1993; Lohmander et al., 1994; Di Cesare et al., 1996), and the high 
concentration remains for many years. However, in advanced OA with cartilage 
erosions and loss of cartilage with denuded bone, no high COMP concentrations 
are observed (Lohmander et al., 1994). In a one-year prospective study of patients 
with hip OA, COMP concentrations in serum were higher in patients with 
progressive disease (Conrozier et al., 1998).  
COMP in synovial fluid and serum has also been tested as a marker candidate of 
OA in horses. The concentrations of COMP in synovial fluid from joints with 
aseptic and septic arthritis were significantly lower compared to normal joints, 
with no difference between aseptic and septic joints (Misumi et al., 2001). A 
higher proportion of fragmented COMP was also found in these joints.   30
Additionally, low concentrations of COMP and KS in serum were found in horses 
(unknown breeds) with synovitis, osteochondral chip fractures and osteochondritis 
dissecans. The concentration of COMP in synovial fluid also varies between 
different joints (Viitanen et al., 2000). Higher concentrations of COMP, total 
protein, and GAGs were found in synovial fluid from the coffin joint as compared 
to the fetlock joint, possibly reflecting differences in load. 
Studies of experimental induced arthritis in rats showed high serum levels of 
COMP reflecting cartilage destruction, and fibrinogen and hyaluronan reflecting 
inflammation (Larsson et al., 2002). Inflammation and tissue destruction appears 
to be uncoupled processes in human RA and in animal models of RA (Joosten et 
al., 1999a; Joosten et al., 1999b; Roux-Lombard et al., 2001). An increased 
concentration of COMP can be an indicator of anabolic and /or catabolic processes 
in the cartilage. Inflammatory joint diseases, such as RA and PsoA include both 
synovial inflammation and tissue destruction and PsoA patients had a high 
concentration of sf-COMP and a low concentration of sf-aggrecan compared to 
patients with destructive and non-destructive RA (Månsson et al., 2001b). The low 
concentration of sf-aggrecan and high concentration of sf-COMP in PsoA may 
reflect a repair process where the high concentration of COMP primarily 
represents release of newly synthesised molecules. 
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Aims of thesis 
 
The overall aim was to study the metabolism of equine articular cartilage in 
relation to training and injury using the pattern of release of extracellular matrix 
proteins into the synovial fluid as a biologic window. Detection of subclinical 
biochemical cartilage destruction may provide knowledge into the pathogenesis of 
OA. 
 
The specific objectives were: 
* To define the baseline values for COMP, aggrecan, and collagen type II 
degradation products in synovial fluid and serum in normal middle carpal joints 
from two horse breeds with different athletic background. Additionally, to identify 
the relationship, if any, between the concentration of macromolecules released into 
the synovial fluid and serum and the extent of articular cartilage lesions. 
 
* To measure changes in the concentration of COMP, aggrecan, and collagen 
type II degradation products released into synovial fluid in the middle carpal joints 
from racehorses during a long term training program (24 month) and to investigate 
the synthesis of COMP in dynamic compressed cartilage explants from horses 
with different athletic backgrounds. 
 
* To delineate the presence and distribution of COMP in relation to collagen 
fibril thickness in different matrix compartments and zones from loaded and 
unloaded areas of proximal articular cartilage of the third carpal bone. 
 
* To determine the concentration of COMP and aggrecan released into synovial 
fluid of carpal joints in racehorses with acute lameness and to identify any 
relationship between the macromolecular concentration and the type of joint lesion 
present.   32
Present investigation 
 
Three common horse breeds in Sweden are the Swedish Warmblood horse (riding 
horse), Thoroughbred horse (galloping horse) and Standardbred trotter (trotter). 
The trotter and galloping horse are the two most popular racehorses and the 
different gait at which the horses perform creates different loading conditions 
within the carpal joints—leading to differences in the location of lesions and type 
of fractures to the third carpal bone (Palmer, 1986; Schneider et al., 1988). Greater 
force is generated in the carpal joints during the gallop as compared to trot, which 
is a more balanced gait. However, the third carpal bone is subjected to more 
frequent repetitive cyclic load during trotting, though with lower magnitude forces 
than in the gallop (Schneider et al., 1988). Racehorses start to train at an early age 
(1.5 years) and to qualify for youth races at 2.5 years. Riding horses used for 
competition and pleasure riding start their training at 2 to 3 years of age, with a 
slower progression of intensity during the first years compared to the racehorses. 
The riding horse will qualify for advanced competition at the age of 8-10 years. 
This thesis focuses on these three horse breeds, with different athletic 
backgrounds. Synovial fluids are sampled from the left middle carpal joints (paper 
I, II, IV) and radiocarpal joints (paper IV), which are high-motion joints subjected 
to high load with frequent micro-trauma and subsequent cartilage destruction and 
subchondral bone sclerosis. The studies concentrate on the left carpal joint often 
associated with lameness in the racehorse (Bramlage, 1988). Also, trotters in 
Sweden race counter clock-wise with subsequent lameness more frequently 
originating in the left carpal joint than the right carpal joint (Magnusson, Thesis 
1985). Only one joint is evaluated, since different joints normally express varying 
concentrations of synovial fluid constituents (Viitanen et al., 2000) and the 
cartilage metabolism of macromolecules in one joint can influence the 
contralateral joint (Dahlberg et al., 1994). 
Molecular markers of cartilage metabolism would be powerful tools in 
investigations into the pathogenic mechanisms of articular cartilage destruction in 
the athletic horse. Much research has been done to develop biochemical markers 
that identify and quantify cartilage breakdown. To be able to detect and monitor 
the early stages of osteoarthritic changes, when the balance between anabolic and 
catabolic processes is disturbed, is crucial for an understanding of the 
pathogenesis of OA.  
The biochemical and morphological methods used are thoroughly described in 
four papers included in the Thesis. The following antibodies have been used: a) 
rabbit polyclonal antibody against purified porcine collagen type II, denatured 
thermally (paper I, II), not cross reacting with any of the other collagen types, but 
with collagen type II from rat and horse. After immunoadsorption against native 
collagen type II by ELISA it did not react with native collagen type II from any 
species; b) rabbit polyclonal antibody against the CS-region of the core protein of 
aggrecan (paper I, II, IV); and c) rabbit polyclonal antibody against bovine COMP 
reacting with intact protein as well as fragments of the pentamer ín the ELISA 
(paper I, II, IV) and immunolocalisation (paper II, III).   33 
Summary of papers 
 
Concentration of collagen, aggrecan and cartilage oligomeric 
matrix protein (COMP) in synovial fluid from equine middle 
carpal joints (Paper I) 
Hypothesis: The concentration of cartilage derived molecular markers in synovial 
fluid and serum correlates to tissue destruction of cartilage in the middle carpal 
joint, with higher values in osteoarthritic joints with cartilage degeneration.  
 
To test this, we evaluated metabolic activity in the cartilage of the third carpal 
bone by measuring the release of COMP, aggrecan, and collagen type II molecules 
into the synovial fluid and serum and correlating the values to different cartilage 
lesions and metabolically labelled cartilage explants.  
Seventy-three horses of two different breeds, trotters (52) and riding horses (21) 
aged 1 to 19 years, with different athletic backgrounds having articular cartilage 
with normal appearance or mild, moderate, or severe macroscopic lesions were 
included. A significantly lower concentration of sf-COMP and sf-aggrecan were 
found in trotters with moderate joint lesions as compared to trotters with normal 
articular cartilage. This lower sf-COMP was not present in riding horses, instead, a 
slight increase in concentration was found in joints with moderate lesions 
compared to normal joints and the sf-aggrecan concentration was similar in joints 
with normal articular cartilage and lesions. The COMP content in serum was also 
significantly lower in the trotter with moderate joint lesions and highest in the 
riding horse with normal joints. Also, a correlation between age and lower sf-
COMP was found in the trotters. Additional metabolic labeling confirmed a lower 
synthesis of COMP in cartilage with moderate lesions compared to cartilage with 
normal cartilage or mild lesions. The total content of COMP in the articular 
cartilage was lowest in the trotter with moderate lesions. The content of COMP in 
the cartilage extracts was expressed as mg/wet weight and in relation to µg 
hydroxyprolin, with similar results.  
The level of collagen type II degradation products in synovial fluid was higher 
in the riding horses compared to the trotters (indicating a difference in release of 
molecules in horses with different activity), but no correlation between joint 
lesions and collagen concentrations were found. 
The hypothesis, put forward, could not be proven and the results contradict the 
higher COMP release found in humans with OA. 
Interestingly a correlation between age and lower sf-COMP was found in the 
trotters but not in the riding horses. These results suggest that the trotter, subjected 
to earlier and more intense training than the riding horse, has an altered cartilage 
metabolism. This difference between breeds can reflect a difference in release of 
macromolecules in loaded normal and/or osteoarthritic cartilage. Hence the effect 
of load on articular cartilage achieved during training needed to be further 
evaluated. To shed some light on these questions, the second study was conducted. 
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Altered metabolism of extracellular matrix proteins in articular 
cartilage of intensely training Standardbred trotters (Paper II) 
Hypothesis: Training will increase the turnover of macromolecules in normal 
articular cartilage with a subsequent increase of molecules or fragments into the 
synovial fluid.  
 
To test this hypothesis, we followed 28 trotters during a two-year training 
program from start of training at the age of 1.5 years until high speed racing at 3.5 
years. To minimise effects from variables other than training and age, the horses 
were trained by the same trainer at the same campus during the same time of year, 
and synovial fluid was collected every third month (before 2 days of rest). The 
concentration of COMP, aggrecan and collagen type II degradation products was 
correlated to total amount of training, age, rest and lameness. At each visit, the 
horse was classified as lame or not lame and the values of the macromolecules 
were recorded as coming from a lame or non-lame joint.  
The statistical evaluation was constructed to find possible relationships, and the 
magnitude of any relationship, between the concentration of macromolecules in 
the synovial fluid and each of the parameters measured (age, days of training, days 
of rest, lame/non-lame).  
The concentration of collagen type II degradation products increased with the 
amount of training, indicating degeneration of the collagen network. This was 
found in both lame and non-lame joints. Sf-aggrecan was not significantly 
influenced by the parameters studied. However, a somewhat lower concentration 
of aggrecan was found in the raced horses compared to the non-raced at visit 6. 
Total days of training and the age of the horse influenced COMP concentration in 
both lame and non-lame joints. However, age and total days of training correlated 
strongly to each other, hence the result indicated that both age and load could 
influence COMP metabolism.  
To obtain information on possible mechanisms responsible for the lower COMP 
concentration, an in vitro compression study was undertaken. Cartilage from age-
matched, trained and untrained horses was collected and subjected to 48-h cyclic 
unconfined dynamic load. In the untrained horses, an up-regulation of COMP 
synthesis was seen, and in the cartilage from trained horses a down-regulation of 
the protein was found, though this was not influenced by age. The up-regulation in 
the untrained horses is in agreement with previous results from compression 
studies of bovine cartilage from untrained animals (Wong et al., 1999).  
Our working hypothesis was not supported by the results, instead we concluded 
that long-term strenuous training results in alterations of cartilage metabolism and 
an inhibited ability of the cell to respond with increased synthesis of matrix 
proteins. The down-regulation of COMP synthesis may be one part of the early 
development of cartilage degeneration in osteoarthritic joints.   35 
Ultrastructural immunolocalization of cartilage oligomeric 
matrix protein   (COMP) in loaded and unloaded areas of the 
articular cartilage from the equine third carpal bone (Paper III) 
Hypothesis: Mechanical load creates a structural difference in the articular 
cartilage matrix with changes in collagen fibrils and amount of COMP. 
 
To test this hypothesis, an ultrastructural semi-quantification of COMP was 
undertaken—to compare the delineation of COMP in cartilage matrix from a high 
weight-bearing area in the dorsal radial facet (loaded) and a low weight-bearing 
area in the palmar intermediate facet (unloaded) of the third carpal bone from 
trained and untrained horses.  
The untrained horses often displayed a higher COMP concentration, assessed by 
density of gold markers, in the loaded areas compared to unloaded. Also, 
immunolabeling was higher in the untrained horses compared to the trained 3-
year-old horse, which showed the lowest levels of all horses. The untrained 3-
year-old horse displayed the highest density of gold markers in the loaded area of 
all horses. This marked difference between the age-matched horses clearly 
indicates that the high-speed training of the horse has a drastic effect on cartilage 
metabolism. The collagen fibril diameter was also measured and the young 
untrained horses had a similar diameter distribution in unloaded and loaded areas. 
The 3-year-old horses, also showed a similar distribution of fibril diameter, but the 
trained 3-year-old presented a higher proportion of thin fibrils in loaded areas 
compared to unloaded. This was not found in the three-year-old untrained horse, 
where a tendency to a somewhat higher proportion of thicker fibrils could be seen 
in loaded areas.  
In conclusion, an altered immunolabeling of COMP with low concentration in 
all compartments of articular cartilage matrix from an intensely trained horse is 
presented— supporting our hypothesis. An indication of altered collagen fibril 
diameter together with low COMP content indicates the need for further studies 
into the effect of strenuous training with high load on the equine articular 
cartilage.   36
Enhanced concentration of COMP (cartilage oligomeric matrix 
protein) in osteochondral fractures from racing Thoroughbreds 
(Paper IV) 
Hypothesis: A correlation between COMP and aggrecan concentration in synovial 
fluid and macroscopic lesions of articular cartilage, osteochondral fractures and 
ligament tears in acutely lame horses exists.  
 
Sixty-three lame horses (49 trotters and 14 galloping horses: 2.5-8.3 years old) 
in conventional training/racing with acute lameness underwent arthroscopy to the 
intercarpal or middle carpal joints and synovial fluid samples were collected. The 
joint pathology was characterised macroscopically and correlated to the sf-COMP 
and sf-aggrecan. No correlation between sf-COMP and age was present in the 
galloping horses, however, sf-COMP decreased with age in the trotters. 
The concentration of COMP was higher in galloping horses with osteochondral 
fractures than in trotters and galloping horses with osteoarthritic lesions. The 
concentration also increased in correlation to days after injury. The chondrocytes 
in middle and deep zones of the articular cartilage in the osteochondral fragments 
from two horses expressed COMP mRNA, in contrast to the articular cartilage of 
the third carpal bone on the opposite side of the fracture with no expression 
detected. In the synovial fluid from a joint with osteochondral fracture only intact 
COMP was present, whereas, fragmented COMP was more prominent in synovial 
fluid from a joint with osteoarthritic lesions. The concentration of aggrecan did not 
differ between the two breeds, or between different joint pathology. 
The increased concentration of COMP in joints with osteochondral fractures and 
the dominance of intact COMP together with expression of COMP mRNA in the 
fragments, suggests that the protein is up-regulated in this type of pathology where 
compressive load of the osteochondral fragment is low.  
Our hypothesis was partly supported by the findings of significant elevation of 
sf-COMP in the joints from galloping horses with osteochondral fractures. The 
elevated COMP concentration in the joints of the galloping horses can be a useful 
clinical marker for carpal joint osteochondral fragments.   37 
Conclusions 
 
●  The concentration of COMP, aggrecan and collagen type II degradation 
products in synovial fluid from trotters with moderate articular cartilage lesions is 
lower than in riding horses with similar lesions. The COMP synthesis and total 
amount of COMP in explants from trained trotters are lower compared to 
untrained horses. This indicates that chondrocytes from cartilage subjected to high 
and repeated load have a low capacity to synthesise COMP. The baseline values 
differed between the two horse breeds. 
 
● The concentration of COMP in synovial fluid from young trotters in training 
decreases with the amount of training and higher age. 
 
●  Cartilage explants—collected from trained horses—subjected to dynamic 
unconfined compression, in vitro, showed inhibition of COMP synthesis compared 
to cartilage from age-matched untrained horses. 
 
●  COMP concentration, assessed by immunolabeling is higher in loaded areas 
compared to unloaded areas of articular cartilage in untrained horses. Low COMP 
levels are seen in both loaded and unloaded areas of a trained horse.  
 
● A high concentration of COMP in synovial fluid is seen in galloping horses with 
osteochondral fractures compared to trotters with normal articular cartilage and 
articular cartilage with moderate lesions or osteochondral fractures. The articular 
cartilage of the osteochondral fragments expressed COMP mRNA and the 
synovial fluid contained intact COMP molecules, indicating COMP synthesis with 
increased release or primary increased release of COMP from the matrix.  
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General discussion 
 
A progressive destruction of articular cartilage in combination with subchondral 
bone changes, leading to pain, lameness and subsequent loss of joint function is 
seen in OA. The exact aethiopathogenesis behind the cartilage degeneration in OA 
of equine athletes is poorly understood. A high and/or repetitive load is believed to 
play a significant role in the destruction of the articular cartilage of the dorsal 
radial facet on the third carpal bone in the middle carpal joint of racehorses 
(Bramlage et al., 1988; Palmer et al., 1994).  
The work in this thesis focused on three cartilage matrix macromolecules; 
COMP, aggrecan, and collagen type II—each reflecting different functional units 
of the cartilage. The present studies concentrated on the left middle carpal joint 
focusing on the third carpal bone in order to minimise variations of biomechanics 
and patterns of joint disease. Also, metabolic changes in one joint can influence 
the contralateral joint (Dahlberg et al., 1994). 
The overall aim was to detect subclinical biochemical articular cartilage 
destruction in the horse with the aid of cartilage-derived macromolecules in the 
synovial fluid. The metabolic reactions of articular cartilage to high repetitive load 
of the dorsal radial facet in the middle carpal joint and its role in pathogenesis of 
OA were also of great interest. 
In paper I, we measured the concentrations of COMP, aggrecan or fragments of 
these molecules and collagen type II degradation products released to synovial 
fluid and serum from trotters and riding horses with articular cartilage 
degeneration or normal joints. Sf-COMP and sf-aggrecan decreased in the joints 
with moderate cartilage lesions from the trotters compared to the normal joints. 
This decrease was not found in the joints from riding horses. A marked difference 
between normal and osteoarthritic cartilage was seen in COMP synthesis 
(identified by metabolic labeling), where the lowest amount was found in articular 
cartilage with moderate lesions from the trotter. Also, no increase of sf- GAG 
from the metacarpophalangeal joints (van den Boom et al., 2004) and sf-COMP 
(unknown joints) (Misumi et al., 2001) of horses (unknown breed and athletic 
background) with OA is seen.  
In contrast, an increase in COMP and aggrecan concentration is found in joints 
with rheumatoid arthritis, OA, reactive arthritis, and juvenile arthritis in man 
(Saxne & Heinegård, 1992). A distinct difference between horse and man is that 
the equine athletes will continue to expose the articular cartilage to a high load, 
while the human patient will not. A lower concentration of collagen type II was 
also found in the trotter compared to the riding horse; this was not correlated to the 
cartilage lesions or age. Lower hydroxyproline concentration in synovial fluid is 
correlated to cartilage degeneration index (CDI) in the metacarpophalangeal joints 
(van den Boom et al., 2004) and age. The difference in results can be explained by 
different joints and different classification and activity of cartilage lesions. Using 
the more precise CDI classification (Brommer et al., 2003b) may have showed a 
correlation with cartilage lesions and the lower collagen type II concentration of 
the trotters. The reported age difference is most significant between the neonates 
and 5-month-old foals. At the age of 1-4 years, the levels are stable throughout the   39 
lifespan of the horses (van den Boom et al., 2004), which explains the lack of age 
correlation in our study.  
In conclusion paper I showed that there is a difference between two breeds (with 
different activity profiles) in the articular cartilage metabolic activity of the middle 
carpal joint. The lower metabolic activity can be related to intensive high load 
training experienced by trotters. To test the hypothesis that strenuous training and 
lameness alter the articular cartilage metabolic activity and influence the release of 
COMP, aggrecan, and collagen type II in synovial fluid, a longitudinal study with 
young trotters in training was set up in paper II.  
Young trotters were sampled every third month during a long-term training 
program (24 months). Due to economic limitations it was not possible to sample 
an age-matched non-exercising group. However, the correlations between the 
amount of training and lameness remains valid and important observations were 
made. The concentration of COMP decreased with increasing age (19.5 to 40 
months) and total days of training. Also, the concentration of collagen type II 
degradation products increased with total days of training. Additionally, in vitro 
dynamic compression of cartilage explants from trained and untrained, age-
matched horses showed a decrease of COMP synthesis in the compressed explants 
compared to the free swelling explants from trained horses. An increase of COMP 
synthesis was found in the explants from the untrained horses. Stimulation of 
COMP synthesis is always found when untrained bovine cartilage is compressed 
in vitro (Wong et al., 1999). Hence, it was concluded that the strenuous training 
with high load to the articular cartilage would alter the cartilage metabolism with a 
subsequent lower COMP synthesis.  
To further evaluate the effect of load on the presence of COMP, an 
ultrastructural semi-quantitative delineation of the protein was done in loaded and 
unloaded areas of trained and untrained horses. The samples from the trained 
trotter displayed a very low amount of COMP, assessed by gold-markers, in both 
territorial and interterritorial matrix compartments from two different depths of the 
cartilage. The COMP concentration was much higher in the cartilage from the 
untrained horses, where often the loaded areas showed higher levels compared to 
unloaded areas, indicating a stimulatory effect of load. Riding horses were 
compared to trotters, since their activity profiles are different and the trotters are 
subjected to an earlier and more intensive training, aimed to qualify for fast speed 
racing at the age of 2 years. The galloping horse also is trained and raised at this 
early age. However, the difference in motion results in different mechanical load 
of the carpal joints with different types of fractures. The trotter experiences mostly 
large and deep fractures, while galloping horses develop small superficial fractures 
in the carpal joints (Schneider et al., 1988).  
In paper IV, COMP and aggrecan concentrations in synovial fluids from acutely 
lame trotters and galloping horses, subjected to arthroscopy, were evaluated and a 
higher concentration of sf-COMP in galloping horses with osteochondral fractures 
compared with the trotters and galloping horses with OA was found. The articular 
cartilage of the unloaded osteochondral fragments expressed COMP mRNA, in 
contrast to the articular cartilage on the opposite side of the fracture, still subjected 
to load. Intact COMP was present in the joint with osteochondral fracture, which 
suggests an up-regulation of this protein where compressive loading of the 
fragment is low. Dynamic load can stimulate the chondrocyte to active synthesis.    40
The cells may respond to changes in cell shape (deformation), sensed by 
cytoskeletal proteins or stretch-activated ion-channels, or to changes in integrin- 
(Wu & Chen, 2000) and IL-4- signalling (Salter et al., 2002). A non-physiological 
high load may lead to cell necrosis or apoptosis and/or production of MMPs and 
cytokines. An increased expression of fibronectin fragments is present in OA (Zie 
et al., 1992; Homandberg et al., 1999) and these fragments induce the production 
of MMPs and cytokines (Homandberg et al., 1997). This can result in higher 
levels of protein fragments in the synovial fluid; though in a long-term period of 
high repetitive load, the cell may react with altered integrin composition and 
fatigue of the cell where the mechanical signal transducers are blocked. The 
decreased levels of proteins found in the present studies can be due to cell fatigue.  
The results from this thesis clearly indicate that dynamic compression at high 
load and high frequency, as a result from strenuous training, has drastic effects on 
the metabolism of articular cartilage from the dorsal radial facet of the equine third 
carpal bones.  
Development of new assays, quantifying fragments or detecting epitopes of 
matrix molecules specific for anabolic and catabolic processes will aid in the 
understanding of factors responsible for joint failure in the equine athletes. Also, 
studies focusing on cell responses, through integrins (receptors for specific 
proteins), during cyclic compression at different amplitudes and frequencies, can 
clarify how mechanical signals are transduced and how the chondrocyte will 
respond. Cell reaction will depend on the magnitude and rate of load as well as the 
duration and nature of the loading pattern (constant vs. intermittent).   41 
Future Research 
 
The results presented in this thesis indicate that much research into tissue reactions 
of mechanical load is needed. Also, the role of the interaction between bone and 
cartilage at their interface in OA must be clarified. In particular, the following 
areas should be investigated: 
  
In cartilage, matrix molecules interacting with cell surface receptors and therefore 
of relevance in understanding cellular responses to events in the matrix should be 
one focus. An example of such a molecule is chondroadherin. Whether this 
integrin binding molecule is also involved in modulating responses to mechanical 
load is another issue of relevance. Other such molecules like fibronectin are less 
specific for cartilage, although there are specific splice variants. This protein binds 
a different integrin than chondroadherin. Molecules that appear to provide readout 
for mechanical responses include COMP and further studies into the role of this 
protein and its variability should be informative. Molecules like CILP change 
early in the OA-process and delineating its role should be a part of understanding 
the biology of joint diseases. 
 
Studies of responses of cartilage to environmental factors, in attempts to 
understand the apparent altered responses induced by the excessive overload of 
intense training of racehorses, should be conducted. To control the conditions, 
initial studies should focus on in vitro systems, where cartilage explants can be 
loaded and details of the responses can be studied. A compression chamber (for 
unconfined compression) has been constructed, where different load and 
frequencies can be applied, mimicking the load to tissue when the horse is running 
at different speeds. 
 
It is clear that the process in the joint include the bone where alterations of 
sclerosis are observed. Little is known of the molecular events, which represent 
early phenomenon. One molecule of particular interest is bone sialoprotein (BSP), 
which is particularly enriched at the bone part of the interface between cartilage 
and bone, with a role in early bone formation. This molecule is of particular 
interest since it can specifically bind to the integrin subunits α5β3 and therefore 
involved in modulating cellular activities. 
BSP will be analysed in synovial fluid and serum from 28 young trotters trained 
and raced during a long-term training period (paper II). The concentration of BSP 
will be correlated to parameters such as amount of training, lameness, age, bone 
sclerosis, and bone activity determined by radiographic and scintigraphic 
examination. 
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